Engineers Gate Manager LP

Position in FULC — Fulcrum Therapeutics, Inc.

CIK 1620220 NEW YORK, NY

Position in FULC

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$967,256

+$931,202 QoQ

Shares Held

126,109

+907.3% QoQ

Ownership

0.189%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#55

of 168 holders

Holding Since

Sep 2020

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Engineers Gate Manager LP holds $239,656,317 across 145 Biotechnology names. FULC ranks #43 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	158,792	$25,965,667
2	BMRN	Biomarin Pharmaceutical Inc	436,860	$24,678,221
3	BBIO	BridgeBio Pharma, Inc.	243,729	$18,099,315
4	JAZZ	Jazz Pharmaceuticals plc	92,990	$17,579,759
5	ALNY	Alnylam Pharmaceuticals, Inc.	32,502	$10,753,936
6	IONS	Ionis Pharmaceuticals Inc	133,827	$10,049,069
7	TVTX	Travere Therapeutics, Inc.	254,401	$7,558,253
8	ROIV	Roivant Sciences Ltd.	256,447	$7,103,581

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$967,256	126,109	+907.3%	Shares	Sole	2026-05-15
2025-03-31	$36,054	12,519	-50.4%	Shares	Sole	2025-05-15
2024-09-30	$90,085	25,234	+27.1%	Shares	Sole	2024-11-14
2024-06-30	$123,132	19,860	-33.4%	Shares	Sole	2024-08-14
2023-03-31	$84,992	29,822	+39.6%	Shares	Sole	2023-05-15
2022-06-30	$104,644	21,356	+81.4%	Shares	Sole	2022-08-15
2021-06-30	$123,381	11,773	-31.3%	Shares	Sole	2021-08-16
2021-03-31	$201,956	17,144	-13.5%	Shares	Sole	2021-05-17
2020-12-31	$231,986	19,811	-1.5%	Shares	Sole	2021-02-16
2020-09-30	$159,432	20,105	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.